Synergistic Efficacy of Gedatolisib and Darolutamide in Prostate Cancer to Overcome Resistance to Androgen-Targeted Therapy

Salmaan Khan(Acuity Technologies (United States)), Lance Laing(Acuity Technologies (United States))
International Journal of Molecular Sciences
December 6, 2025
Cited by 0


Related Papers